Back to Search
Start Over
Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Effects of treatment with duvelisib and ibrutinib on the numbers of T cells in in mice receiving samples from the same patients in Figure 6.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....5f62bd30e4c22c35943a1b68a41f5048
- Full Text :
- https://doi.org/10.1158/1078-0432.22652509